GLP-1 Medications and Fertility: What You Need to Know Before Starting Treatment

If you're considering GLP-1 medications like semaglutide or tirzepatide and wondering about your fertility or family planning goals, you're asking exactly the right questions. The relationship between GLP-1 therapy and fertility is more complex and more important than many people realize, especially for women of childbearing age. Understanding how these medications interact with your reproductive health can help you make informed decisions about your treatment timeline.

Understanding GLP-1 Medications and Reproductive Health

GLP-1 receptor agonists work by mimicking a natural hormone in your body that regulates blood sugar and appetite. Medications like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) have become increasingly popular for weight management and metabolic health.

But here's what matters for fertility: these medications haven't been adequately studied in pregnant women, and animal studies have shown potential risks to developing fetuses. That's why understanding the fertility implications is crucial before starting treatment.

How GLP-1 Medications Can Improve Fertility

Paradoxically, GLP-1 medications may actually improve fertility for many women, particularly those with polycystic ovary syndrome (PCOS) or obesity-related infertility. Here's how:

Weight Loss and Hormonal Balance

Excess weight can disrupt reproductive hormones, leading to irregular ovulation or anovulation (lack of ovulation). When GLP-1 therapy helps reduce body weight, it often restores more regular menstrual cycles and improves ovulation.

Studies show that even modest weight loss of 5-10% can significantly improve fertility outcomes in women with PCOS or obesity. GLP-1 medications can facilitate this weight loss, potentially restoring fertility faster than many people expect.

Insulin Resistance and PCOS

For women with PCOS, insulin resistance is often a core issue affecting fertility. GLP-1 medications improve insulin sensitivity, which can help regulate menstrual cycles, reduce androgens (male hormones), and improve egg quality.

This improvement in metabolic health can translate to better fertility outcomes, sometimes catching women off guard if they weren't planning for pregnancy.

The Critical Pregnancy Planning Window

Here's the most important information you need: if you're taking GLP-1 medications and planning to become pregnant, you need to stop the medication well before trying to conceive.

Recommended Timeline

Current manufacturer guidelines recommend discontinuing GLP-1 medications at least two months before attempting pregnancy. This timeline is based on how long these medications stay in your system:

• Semaglutide has a half-life of about one week, meaning it takes roughly five weeks to clear from your body
• Tirzepatide has a similar clearance timeline
• The two-month recommendation provides a safety buffer to ensure the medication is fully eliminated

Why This Matters

Animal studies have shown potential risks including fetal abnormalities and pregnancy loss. While we don't have comprehensive human data, the precautionary principle applies: it's better to be safe and allow adequate clearance time.

Additionally, because these medications can improve fertility, some women conceive more easily than expected once metabolic health improves. This makes planning and timing especially important.

What Happens If You Become Pregnant While Taking GLP-1s

If you discover you're pregnant while taking a GLP-1 medication, don't panic, but do contact your healthcare provider immediately. You should stop the medication right away.

Your doctor will likely want to monitor your pregnancy more closely and may refer you to a maternal-fetal medicine specialist. They may also report your pregnancy to the manufacturer's pregnancy registry, which helps gather safety data for future patients.

The good news is that many women who've become pregnant while taking these medications have had healthy pregnancies, but medical supervision is essential.

Contraception Considerations During GLP-1 Therapy

If you're not planning pregnancy, reliable contraception is important while taking GLP-1 medications. Here's a crucial detail many people don't know: GLP-1s can affect how well oral birth control pills work.

Birth Control Effectiveness

GLP-1 medications slow stomach emptying, which can potentially reduce the absorption of oral contraceptives, especially during the first weeks of treatment or after dose increases when nausea and vomiting are most common.

If you're using oral contraceptives, consider switching to a non-oral method (IUD, implant, patch, or ring) or using backup contraception, especially during the first month of GLP-1 therapy.

GLP-1 Medications and Male Fertility

While most fertility concerns around GLP-1s focus on women, men planning to father children should also be informed. The good news: current evidence suggests GLP-1 medications don't negatively impact male fertility.

In fact, similar to women, men may see improvements in fertility through weight loss and better metabolic health. Obesity in men is associated with lower testosterone levels, reduced sperm quality, and erectile dysfunction—all of which may improve with weight loss.

However, data on male fertility and GLP-1s is still limited. Men planning to conceive should discuss their treatment with their healthcare provider, though the strict discontinuation timeline required for women doesn't apply to men.

Planning Your Timeline: Weight Loss vs. Family Planning

If you're considering both GLP-1 therapy and pregnancy in the near future, strategic timing matters. Here are some scenarios to consider:

If you're planning pregnancy within 6 months: You might want to delay starting GLP-1 therapy until after pregnancy and breastfeeding, focusing instead on other approaches to metabolic health.

If you're planning pregnancy in 6-12 months: Starting GLP-1 therapy might help improve your metabolic health and fertility before conception, with adequate time to discontinue safely.

If pregnancy isn't in your immediate plans: GLP-1 therapy can proceed, but use reliable non-oral contraception and maintain open communication with your provider about your timeline.

Breastfeeding and GLP-1 Medications

Current guidelines recommend avoiding GLP-1 medications while breastfeeding. We don't have adequate data on whether these medications pass into breast milk or how they might affect a nursing infant.

If you're planning to breastfeed, you'll need to wait until you've finished nursing before restarting GLP-1 therapy. This is an important consideration for your overall timeline and planning.

From the Ozari Care Team

The intersection of GLP-1 therapy and fertility planning requires individualized care and timing. If you're considering pregnancy within the next year, discuss your complete timeline with your provider before starting treatment. For women with PCOS or obesity-related infertility, GLP-1s may actually support your fertility goals when used strategically with proper planning for discontinuation before conception.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically Reviewed — Ozari Clinical Content Team (OCCT). Health writers and wellness professionals specializing in GLP-1 therapy, metabolic health, and weight loss medicine. Content reviewed in accordance with Ozari's Editorial Standards. Last reviewed: April 25, 2026.

This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.

Last reviewed: April 25, 2026